Tim Holt

Tim Holt serves as the President and CEO of R2 Technologies, Inc. since July 2017, where efforts focus on empowering providers to deliver reliable results through cold-based treatments, highlighted by the Glacial® Rx system. Prior experience includes roles as Chief Commercial Officer and Vice President of Worldwide Commercial Operations at ZELTIQ from April 2008 to December 2016, playing a critical role in launching the influential "CoolSculpting" technology, leading to significant commercial success and a record-setting acquisition. Earlier experience at Reliant Technologies as a Manager from August 2003 to March 2008 contributed to the market introduction of Fraxel technology, facilitating growth that culminated in an acquisition by Thermage. Tim Holt holds a BBA in Marketing from Ohio University and an MBA in Management from Campbell University.